Cancers, Vol. 12, Pages 1417: Fanconi Anemia Pathway Activation by FOXM1 Is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance
In conclusion, FOXM1 and FANCD2 can be used as prognostic factors that are associated with high risk of recurrence and with anticancer drug resistance properties in NMIBC patients.
Source: Cancers - Category: Cancer & Oncology Authors: Yun-Gil Roh Jeong-Yeon Mun Seon-Kyu Kim Wonyoung Park Mi-So Jeong Tae Nam Kim Won-Tae Kim Yung Hyun Choi In-Sun Chu Sun-Hee Leem Tags: Article Source Type: research
More News: Anemia | Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Faconi Anemia | Gastroschisis Repair | Genetics